$ 3.04
Today's Range
$3.04 - $3.11
52-Week Range
$3.04 - $9.05
Market Cap


(NYSEAMERICAN:PHGE) BiomX Inc., a clinical stage company, develops bacteriophage-based therapies for the treatment and prevention of diseases from the microbiome. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), liver, primary sclerosing cholangitis, and cancer. The company's lead product candidate BX001, which is in phase I that helps to modify the appearance of skin in various skin types, including oily and acne-prone skin type; BX002, a therapeutic phage product to treat IBD; BX003, targets bacteria associated with progressive liver disorder (PSC), a rare inflammatory liver disease; and CRC, targets strains of bacteria found in colorectal cancer tumors. The company has license agreement collaboration with The Weizmann Institute of Science to develop, test, manufacture, produce, and sell microbiome-based therapeutic product candidate; Takeda, develops formulations for phage therapy manufacturing intermediates and for the final form to be administered; Keio University and JSR Corporation, a set of bacterial targets for the development and commercialization of phage therapies to treat IBD; and Janssen Research & Development, LLC to utilize XMarker microbiome-based biomarker discovery platform. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.
Show more

PHGE Stock Price

Statistics Highlights (NYSEAMERICAN:PHGE)

Shares Outstanding 28.19M Beta -
Public Float 16.10M P/E Ratio -
% Short of Float 0.00% Dividend (Yield) -
Held by Insiders 23.87% Ex-Dividend Date
Held by Institutions 23.45% IPO Date Mar 13, 2019

PHGE Financial Summary

Dec 20 Dec 19 Dec 18
Revenue $0.00 $0.00 $0.00
EBITDA $-27.73M $-22.37M $-12.29M
Net Income $-30.09M $-20.56M $-12.72M
Total Assets $70.36M $71.62M $45.33M
Total Cash $36.48M $696.83K $8.60M
Total Debt $5.89M $500.00K $500.00K
Jun 21 Mar 21 Dec 20
Revenue $0.00 $0.00 $0.00
EBITDA $-6.74M $-8.12M $-8.51M
Net Income $-7.34M $-8.40M $-9.14M
Total Assets $61.65M $67.06M $70.36M
Total Cash $46.27M $39.41M $36.48M
Total Debt $5.67M $5.50M $5.89M

PHGE Stock Price History

Biomx Inc Annual Stock Price History

Year Open Close Change
2021 $1.62 $3.04 87.65%
2021 $6.52 $1.62 -75.15%
2020 $9.40 $6.52 -30.64%

Biomx Inc Daily Stock Price History

Date Open High Low Close Change Volume
Jun 17, 2022 $0.68 $0.68 $0.64 $0.66 2.79% 17.69K
Jun 14, 2022 $0.64 $0.65 $0.64 $0.64 -2.73% 10.83K
Jun 9, 2022 $0.66 $0.68 $0.64 $0.66 -2.09% 28.66K


What is today's stock price of Biomx Inc (NYSEAMERICAN:PHGE)?

  • The current stock price of Biomx Inc (NYSEAMERICAN:PHGE) is $3.04.
  • Today PHGE stock price opened at $3.06 after previous close of $3.06.
  • During the day, Biomx Inc stock quote has varied from a low of $3.04 to a high of $3.11.

What is Biomx Inc's 52-week change?

  • PHGE 52-week high stock quote is $9.05, which is 197.70% above the current share price.

Is Biomx Inc a buy?

  • According to 3 analysts, the current consensus recommendation for Biomx Inc stock is "Strong Buy" at an average rating score of 4.67 (out of 5).
  • There are currently 2 "Strong Buy", 1 "Buy", 0 "Hold", 0 "Sell", and 0 "Strong Sell" analysts recommendations for the PHGE stock.
  • The 12 month average price target forecast for PHGE stock is $22.33, representing a 634.60% increase from the current PHGE stock price of $3.04.


How Much is Biomx inc Worth?

Biomx inc's worth today based on market capitalisation is $85.71M

How much dividend does Biomx inc Pay?

The current annualized dividend payout for PHGE stock is $0.00, the dividend yield is 0.00% and the payout ratio is 0.00%.
View More Details on Biomx inc's "Dividend" Section

When is the next earnings date for Biomx inc (NYSEAMERICAN:PHGE)?

Biomx inc is expected to report earnings on August 15 ,2022.
View More Details on Biomx inc's 'Earnings' Section

What is Biomx inc’s Price to Earning (PE) ratio?

PHGE stock also has a Price to Sales (P/S) ratio of 0.00.

What is the Biomx inc's ticker?

Biomx inc trades on the NYSE American stock market in USA under the ticker symbol "PHGE". Biomx inc’s stock symbol can also be displayed as "NYSEAMERICAN:PHGE".

When did PHGE go public?

Biomx inc completed its initial public offering (IPO) on March 13 ,2019.

Who are the owners of Biomx inc?

Biomx inc (NYSEAMERICAN:PHGE) is owned by 23.45% institutional shareholders and by 23.87% insiders. The rest is owned by the public.
Explore More Details on Biomx inc's “Ownership” Section

Who are the key executives of Biomx inc (PHGE)?

Biomx inc's key executive team includes the following managers:

  • Mr. Jonathan Eitan Solomon MBA, CEO & Director (1977)
  • Dr. Sailaja Puttagunta, Chief Medical Officer (1969)
  • Dr. Merav Bassan Ph.D., Chief Devel. Officer (1966)
  • Prof. Rotem Sorek Ph.D., Scientific Founder (NA)
  • Dr. Eran Elinav, Scientific Founder (NA)
  • Dr. Timothy K. Lu, Scientific Founder (NA)
  • Ms. Marina Wolfson, Sr. VP of Fin. & Operations and Sec. (1984)
  • Ms. Noel Kurdi, VP of Investor Relations & Strategy (NA)
  • Ms. Inbal Benjamini-Elran, VP of HR (NA)
  • Mr. Assaf Oron, Chief Bus. Officer (1974)

What is Biomx inc’s Sector & Industry Classification?

Biomx inc (NYSEAMERICAN:PHGE) is classified under the "Healthcare" sector and under the "Biotechnology" industry.

How many employees work for Biomx inc?

Currently the number of employees working for Biomx inc is 95.

Where are Biomx inc's Headquarters?

Biomx inc (NYSEAMERICAN:PHGE) is headquartered in Israel.

What are Biomx inc's Address and Phone Number?

Biomx inc’s mailing address is 7 Pinhas Sapir Street, Ness Ziona, Israel, 7414002.
The company’s phone number is 972 7 2394 2377.

What is the official website for Biomx inc?

Biomx inc’s official website is